Clinical Trial Update: Targeted Naltrexone to Support Individuals Participating in Dry January [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating targeted naltrexone to support individuals participating in Dry January is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Alcohol Misuse | Phase 2 | Status: RECRUITING